Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair

June 2, 2025 updated by: Hôpital Fribourgeois

Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair: a Retrospective Study

The goal of this retrospective observational study is to evaluate whether prophylactic mesh reinforcement during abdominal wall closure can prevent incisional hernias (IH) in patients undergoing open abdominal aortic aneurysm (AAA) repair. The main questions it aims to answer are:

  • Does mesh reinforcement reduce the incidence of incisional hernias?
  • What is the frequency of associated postoperative complications? Researchers will compare the outcomes of patients who underwent mesh-reinforced closures to literature-reported outcomes for non-mesh cases to assess differences in IH incidence and complications.

Participants will:

  • Undergo clinical follow-ups and abdominal ultrasounds to detect IH.
  • Complete quality-of-life questionnaires (EQ-5D and PROMIS).

Study Overview

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult patients who underwent open abdominal aortic aneurysm (AAA) repair with prophylactic retromuscular mesh reinforcement at the Fribourg Cantonal Hospital between 2019 and 2024.

Description

Inclusion Criteria:

  • Adult patients (≥18 years old) who underwent open abdominal aortic aneurysm (AAA) repair with prophylactic retromuscular mesh reinforcement between January 2019 and January 2024
  • Availability of complete medical records, including preoperative history, surgical details, and postoperative follow-up data
  • Attendance at a clinical follow-up examination at least one year after the procedure
  • General informed consent signed for the use of medical data for research purposes

Exclusion Criteria:

  • Patients with incomplete or missing medical records, including preoperative, intraoperative, or follow-up data
  • Patients who required a re-laparotomy involving incision or suture of the prophylactic mesh and subsequently developed an incisional hernia.
  • Patients who did not attend the required clinical follow-up examination at least one year postoperatively.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Prophylactic mesh reinforcement after open aortic aneurysm repair
Patients who underwent open abdominal aortic aneurysm (AAA) repair with prophylactic retromuscular mesh reinforcement at the Fribourg Cantonal Hospital between 2019 and 2024.
Prophylactic retromuscular mesh placement involves reinforcing the abdominal wall during closure after open abdominal aortic aneurysm (AAA) repair to prevent incisional hernias. This technique creates a retro-muscular space by carefully dissecting the rectus abdominis muscles from the posterior rectus sheath. A self-gripping polyester mesh or composite mesh is placed in this space, extending 4 cm beyond the midline on each side, ensuring tension-free coverage. The mesh is secured at key points, and the rectus sheaths are closed with continuous sutures. This approach leverages the anatomical integrity of the abdominal wall to reduce hernia risk without increasing postoperative complications.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of incisional hernias
Time Frame: january-april 2025
Incisional hernia will be evaluated trough clinical examination and ultrasound assessement
january-april 2025

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operative time
Time Frame: january-april 2025
will be searched in the operation protocols
january-april 2025
Rate of fascial dehiscence
Time Frame: january-april 2025
Fascial dehiscence will be searched in the patient's records
january-april 2025
Rate of seromas
Time Frame: january-april 2025
will be searched in the patient's records
january-april 2025
Rate of surgical site infection
Time Frame: january-april 2025
will be searched in the patient's records
january-april 2025
Rate of hematomas
Time Frame: january-april 2025
will be searched in the patient's records
january-april 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2025

Primary Completion (Estimated)

October 31, 2025

Study Completion (Estimated)

October 31, 2026

Study Registration Dates

First Submitted

December 31, 2024

First Submitted That Met QC Criteria

December 31, 2024

First Posted (Actual)

January 7, 2025

Study Record Updates

Last Update Posted (Actual)

June 3, 2025

Last Update Submitted That Met QC Criteria

June 2, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incisional Hernia

Clinical Trials on Prophylactic retromuscular mesh reinforcement

Subscribe